Pharma News India

The move is in line with the niche foray strategy of Sun Pharma.

Mumbai, March 5, 2015: Sun Pharmaceutical Industries has acquired the opiates business of GlaxoSmithKline (GSK) in Australia. The move is in line with the strategy to enter areas where the competition is limited.


The company has signed a marketing and supply agreement with Yemen's Al-Mugdh Pharma.

New Delhi, March 2, 2015: Dr Datsons Labs has signed a marketing and supply agreement with Yemen's Al-Mugdh Pharma. The company plans to sell anti-malarial drugs in Yemen under the agreement.


The drug is the generic version of AbbVie Inc's blood pressure drug.

New Delhi, February 26, 2015: Glenmark Pharmaceuticals has received approval from the US health drug regulator to sell the generic version of AbbVie Inc's blood pressure drug Tarka in the US market.


The first biosimilar product, Accofil, is used to treat immune system disorders.

New Delhi, February 23, 2015: Intas Pharmaceuticals has launched its first biosimilar product, Accofil, in Europe. The product is used to treat immune system disorders. The company said in a statement that it has launched its first biosimilar, filgrastim, in Europe through its wholly owned s...


The move will help in reducing dependence on China for import of bulk drugs

New Delhi, February 18, 2015: The Government of India plans to introduce strategies to improve the bulk drug manufacturing capacity in the country. The move will help in reducing dependence on China for import of bulk drugs.


Comment!

 
 






* Indicates mandatory field.
Please wait while comments are being sent...